FLT3 and acute myeloid leukemia: There is also growing evidence that NFAT signalling can enable therapy resistance in myeloid leukaemias [13, 14] and enable AML development, such as in AML cells with the internal tandem duplication in FLT3 (FLT3ITD) [15].